— Know what they know.
Not Investment Advice
Also trades as: LMDXW (NASDAQ) · $vol 0M

LMDX NASDAQ

LumiraDx Limited
1W: +15.1% 1M: +60.0% 3M: -83.2% 1Y: -98.7%
$0.02
Last traded 2025-06-17 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $5.1M mcap

📊 Key Metrics

TTM
$127M
Revenue
-68.2% YoY
$-339M
Net Income
-117.3% YoY
$-143M
Free Cash Flow
+36.0% YoY
-47.1%
Gross Margin
-230.6%
Op. Margin
-236.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE342.9%
ROA-74.1%
ROIC-147.4%

Valuation

P/E-0.0
P/B-0.0
EV/EBITDA-3.3

Leverage

Debt/Equity-1.88
Current Ratio0.45
Interest Cov.-1.4x

Quality Scores

Piotroski F1/9
Altman Z-6.90
Beneish M-5.43

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms